PortalPublikationenLack of Evidence for an Association between Previous HEV Gen...

Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General

Standard

Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General. / Pischke, Sven; Tamanaei, Sarah; Mader, Maria; Wiesch, Julian Schulze zur; Petersen-Benz, Christine; Haddad, Munif; Addo, Marylyn; Schmidt, Tilman; Huber, Tobias B.; Krebs, Christian F.; Steinmetz, Oliver M.; Turner, Jan E.; Hoxha, Elion; Horvatits, Thomas.

in: PATHOGENS, Jahrgang 11, Nr. 1, 18, 23.12.2021.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Pischke, S, Tamanaei, S, Mader, M, Wiesch, JSZ, Petersen-Benz, C, Haddad, M, Addo, M, Schmidt, T, Huber, TB, Krebs, CF, Steinmetz, OM, Turner, JE, Hoxha, E & Horvatits, T 2021, 'Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General', PATHOGENS, Jg. 11, Nr. 1, 18. https://doi.org/10.3390/pathogens11010018, https://doi.org/10.3390/pathogens11010018

APA

Pischke, S., Tamanaei, S., Mader, M., Wiesch, J. S. Z., Petersen-Benz, C., Haddad, M., Addo, M., Schmidt, T., Huber, T. B., Krebs, C. F., Steinmetz, O. M., Turner, J. E., Hoxha, E., & Horvatits, T. (2021). Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General. PATHOGENS, 11(1), [18]. https://doi.org/10.3390/pathogens11010018, https://doi.org/10.3390/pathogens11010018

Vancouver

Pischke S, Tamanaei S, Mader M, Wiesch JSZ, Petersen-Benz C, Haddad M et al. Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General. PATHOGENS. 2021 Dez 23;11(1). 18. https://doi.org/10.3390/pathogens11010018, https://doi.org/10.3390/pathogens11010018

Bibtex

@article{26d2f0e1021f4066ae493de913a616ba,
title = "Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General",
abstract = "Among numerous other immune-mediated diseases, glomerulonephritis has also been suspected to be an extrahepatic manifestation of HEV infection. In this prospective study, we tested 108 patients with glomerulonephritis and 108 age- and sex-matched healthy controls at the University Hospital Hamburg Eppendorf, Hamburg, Germany, for anti-HEV IgG (Wantai test) as a marker for previous HEV exposure. A total of 24 patients (22%) tested positive for anti-HEV IgG. Males tended to be more frequently anti-HEV IgG positive (29%) in comparison to females (16%). However, this does not reach statistical significance (p = 0.07). Anti-HEV IgG positive patients were older in comparison to negative patients (mean 53 vs. 45 years, p = 0.05). The kidney function seems to be slightly decreased in anti-HEV IgG positive patients in comparison to and anti-HEV IgG negative patients basing on creatinine (p = 0.04) and glomerular filtration rate (GFR) (p = 0.05). Slightly higher values of bilirubin could be found in IgG positive patients (p = 0.04). Anti-HEV-IgG seropositivity rate (22%) in glomerulonephritis patients, did not differ significantly in comparison to an age- and sex-matched control cohort of healthy blood donors (31/108 positive, 29%). A total of 2/2 patients with membranoproliferative glomerulonephritis (MPGN) tested anti-HEV IgG positive (p = 0.002 in comparison to glomerulonephritis patients with other subtypes). In conclusion, our findings indicate that previous HEV exposure in a region where GT3 is endemic is not associated with glomerulonephritis in general. However, the subgroup of MPGN patients should be investigated in future studies. Furthermore, future studies are needed to investigate whether the observed association between anti-HEV IgG positivity and reduced GFR in glomerulonephritis patients is HEV associated or is an age-related effect.",
author = "Sven Pischke and Sarah Tamanaei and Maria Mader and Wiesch, {Julian Schulze zur} and Christine Petersen-Benz and Munif Haddad and Marylyn Addo and Tilman Schmidt and Huber, {Tobias B.} and Krebs, {Christian F.} and Steinmetz, {Oliver M.} and Turner, {Jan E.} and Elion Hoxha and Thomas Horvatits",
year = "2021",
month = dec,
day = "23",
doi = "10.3390/pathogens11010018",
language = "English",
volume = "11",
journal = "PATHOGENS",
issn = "2076-0817",
publisher = "MDPI AG",
number = "1",

}

RIS

TY - JOUR

T1 - Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General

AU - Pischke, Sven

AU - Tamanaei, Sarah

AU - Mader, Maria

AU - Wiesch, Julian Schulze zur

AU - Petersen-Benz, Christine

AU - Haddad, Munif

AU - Addo, Marylyn

AU - Schmidt, Tilman

AU - Huber, Tobias B.

AU - Krebs, Christian F.

AU - Steinmetz, Oliver M.

AU - Turner, Jan E.

AU - Hoxha, Elion

AU - Horvatits, Thomas

PY - 2021/12/23

Y1 - 2021/12/23

N2 - Among numerous other immune-mediated diseases, glomerulonephritis has also been suspected to be an extrahepatic manifestation of HEV infection. In this prospective study, we tested 108 patients with glomerulonephritis and 108 age- and sex-matched healthy controls at the University Hospital Hamburg Eppendorf, Hamburg, Germany, for anti-HEV IgG (Wantai test) as a marker for previous HEV exposure. A total of 24 patients (22%) tested positive for anti-HEV IgG. Males tended to be more frequently anti-HEV IgG positive (29%) in comparison to females (16%). However, this does not reach statistical significance (p = 0.07). Anti-HEV IgG positive patients were older in comparison to negative patients (mean 53 vs. 45 years, p = 0.05). The kidney function seems to be slightly decreased in anti-HEV IgG positive patients in comparison to and anti-HEV IgG negative patients basing on creatinine (p = 0.04) and glomerular filtration rate (GFR) (p = 0.05). Slightly higher values of bilirubin could be found in IgG positive patients (p = 0.04). Anti-HEV-IgG seropositivity rate (22%) in glomerulonephritis patients, did not differ significantly in comparison to an age- and sex-matched control cohort of healthy blood donors (31/108 positive, 29%). A total of 2/2 patients with membranoproliferative glomerulonephritis (MPGN) tested anti-HEV IgG positive (p = 0.002 in comparison to glomerulonephritis patients with other subtypes). In conclusion, our findings indicate that previous HEV exposure in a region where GT3 is endemic is not associated with glomerulonephritis in general. However, the subgroup of MPGN patients should be investigated in future studies. Furthermore, future studies are needed to investigate whether the observed association between anti-HEV IgG positivity and reduced GFR in glomerulonephritis patients is HEV associated or is an age-related effect.

AB - Among numerous other immune-mediated diseases, glomerulonephritis has also been suspected to be an extrahepatic manifestation of HEV infection. In this prospective study, we tested 108 patients with glomerulonephritis and 108 age- and sex-matched healthy controls at the University Hospital Hamburg Eppendorf, Hamburg, Germany, for anti-HEV IgG (Wantai test) as a marker for previous HEV exposure. A total of 24 patients (22%) tested positive for anti-HEV IgG. Males tended to be more frequently anti-HEV IgG positive (29%) in comparison to females (16%). However, this does not reach statistical significance (p = 0.07). Anti-HEV IgG positive patients were older in comparison to negative patients (mean 53 vs. 45 years, p = 0.05). The kidney function seems to be slightly decreased in anti-HEV IgG positive patients in comparison to and anti-HEV IgG negative patients basing on creatinine (p = 0.04) and glomerular filtration rate (GFR) (p = 0.05). Slightly higher values of bilirubin could be found in IgG positive patients (p = 0.04). Anti-HEV-IgG seropositivity rate (22%) in glomerulonephritis patients, did not differ significantly in comparison to an age- and sex-matched control cohort of healthy blood donors (31/108 positive, 29%). A total of 2/2 patients with membranoproliferative glomerulonephritis (MPGN) tested anti-HEV IgG positive (p = 0.002 in comparison to glomerulonephritis patients with other subtypes). In conclusion, our findings indicate that previous HEV exposure in a region where GT3 is endemic is not associated with glomerulonephritis in general. However, the subgroup of MPGN patients should be investigated in future studies. Furthermore, future studies are needed to investigate whether the observed association between anti-HEV IgG positivity and reduced GFR in glomerulonephritis patients is HEV associated or is an age-related effect.

UR - https://www.mdpi.com/2076-0817/11/1/18

U2 - 10.3390/pathogens11010018

DO - 10.3390/pathogens11010018

M3 - SCORING: Journal article

C2 - 35055966

VL - 11

JO - PATHOGENS

JF - PATHOGENS

SN - 2076-0817

IS - 1

M1 - 18

ER -